NGM BIOPHARMACEUTICALS INC (NGM)

US62921N1054 - Common Stock

1.54  -0.02 (-1.28%)

After market: 1.55 +0.01 (+0.65%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
4.42M55.30M77.90M87.40M103.50M
Operating Expenses
155.88M221.60M198.60M191.20M152.90M
Research and Development
118.04M181.10M161.70M164.00M129.30M
Selling, General, and Administrative Expenses
37.84M40.50M36.90M27.20M23.60M
Operating Income
-151.46M-166.20M-120.70M-103.80M-49.30M
Interest Income/Expense
9.32M3.70M400.00K1.90M6.70M
Other Income/Expense
-234.00K-100.00K-100.00K-600.00K-100.00K
Income Before Taxes
-142.38M-162.70M-120.30M-102.50M-42.80M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-142.38M-162.70M-120.30M-102.50M-42.80M
EBITDA
-149.24M-162.16M-114.61M-97.24M-41.69M
 
Per Share Data
EPS Diluted Total Ops
-1.73-2.03-1.56-1.50-0.64
Non GAAP EPS
-1.72-2.05-1.56-1.49-1.75
 
Statistics
Profit Margin
-3223.34%-294.21%-154.43%-117.28%-41.35%
Operating Profit Margin
-3429.09%-300.54%-154.94%-118.76%-47.63%

All data in USD

Charts